Most bought healthcare stocks in Q1 2025
See which Healthcare stocks institutional investors increased the most in Q1 2025, measured as net growth in reported share positions from Q4 2024 into Q1 2025. Notable additions at the top of this list include GSK PLC-SPON ADR (GSK), BAXTER INTERNATIONAL INC (BAX), OPTION CARE HEALTH INC (OPCH), GERON CORP (GERN). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| GSK | GSK PLC-SPON ADR | 9,402,594 | $721.54M | 0 | 3 | 3 | 0 | 6 |
| BAX | BAXTER INTERNATIONAL INC | 4,592,849 | $609.00M | 0 | 5 | 4 | 0 | 9 |
| OPCH | OPTION CARE HEALTH INC | 4,337,189 | $155.47M | 1 | 1 | 0 | 0 | 2 |
| GERN | GERON CORP | 4,148,400 | $3.76M | 0 | 1 | 0 | 0 | 1 |
| ZTS | ZOETIS INC | 3,771,945 | $637.37M | 0 | 4 | 5 | 0 | 10 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 3,511,400 | $11.69M | 1 | 0 | 0 | 0 | 1 |
| SENS | SENSEONICS HOLDINGS INC | 3,350,539 | $2.38M | 0 | 1 | 0 | 0 | 1 |
| ABSI | ABSCI CORP | 2,689,153 | $5.84M | 0 | 1 | 0 | 0 | 1 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 2,655,323 | $31.40M | 1 | 0 | 1 | 1 | 2 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 2,624,212 | -$82.91M | 0 | 3 | 2 | 1 | 5 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2,529,719 | $137.14M | 0 | 2 | 0 | 1 | 2 |
| RXRX | RECURSION PHARMACEUTICALS-A | 2,481,709 | -$34.42M | 1 | 1 | 0 | 0 | 2 |
| CPRX | CATALYST PHARMACEUTICALS INC | 2,401,474 | $67.38M | 1 | 1 | 0 | 0 | 2 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,141,692 | $917.43K | 0 | 1 | 0 | 0 | 1 |
| BAYRY | BAYER AG-SPONSORED ADR | 2,067,470 | $17.58M | 0 | 1 | 0 | 0 | 1 |
| TEM | TEMPUS AI INC | 1,981,755 | $175.52M | 0 | 1 | 0 | 0 | 1 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 1,863,281 | $449.79M | 1 | 2 | 5 | 0 | 8 |
| MYGN | MYRIAD GENETICS INC | 1,742,013 | -$236.98K | 0 | 1 | 1 | 0 | 2 |
| TALK | TALKSPACE INC | 1,699,850 | $3.19M | 0 | 2 | 0 | 0 | 2 |
| TNYA | TENAYA THERAPEUTICS INC | 1,541,725 | $878.94K | 1 | 0 | 0 | 0 | 1 |
| BEAM | BEAM THERAPEUTICS INC | 1,401,260 | -$10.00M | 0 | 1 | 1 | 0 | 2 |
| WST | WEST PHARMACEUTICAL SERVICES | 1,380,051 | $236.26M | 1 | 1 | 1 | 0 | 4 |
| OCGN | OCUGEN INC | 1,371,651 | $762.75K | 0 | 1 | 0 | 0 | 1 |
| ARDX | ARDELYX INC | 1,351,593 | $6.64M | 1 | 0 | 0 | 0 | 1 |
| CVS | CVS HEALTH CORP | 1,280,125 | $2.27B | 1 | 3 | 6 | 0 | 12 |
| NMRA | NEUMORA THERAPEUTICS INC | 1,259,530 | $1.26M | 1 | 0 | 0 | 0 | 1 |
| PFE | PFIZER INC | 1,219,163 | $12.24M | 2 | 5 | 7 | 0 | 15 |
| TXG | 10X GENOMICS INC-CLASS A | 1,204,256 | -$58.91M | 0 | 2 | 0 | 0 | 2 |
| MASI | MASIMO CORP | 1,140,619 | $190.03M | 2 | 0 | 0 | 0 | 2 |
| HRTX | HERON THERAPEUTICS INC | 1,085,700 | $3.19M | 0 | 1 | 0 | 0 | 1 |
| NVST | ENVISTA HOLDINGS CORP | 1,043,204 | -$12.50M | 0 | 2 | 2 | 0 | 4 |
| BIO | BIO-RAD LABORATORIES-A | 1,039,401 | $92.32M | 0 | 4 | 0 | 0 | 4 |
| ILMN | ILLUMINA INC | 1,029,724 | -$43.28M | 0 | 5 | 1 | 0 | 6 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,002,159 | $1.09M | 0 | 1 | 0 | 0 | 1 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 965,183 | $1.00M | 0 | 1 | 0 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 958,414 | $195.19M | 0 | 3 | 0 | 0 | 3 |
| OGN | ORGANON & CO | 940,289 | $13.80M | 0 | 3 | 0 | 0 | 3 |
| GBIO | GENERATION BIO CO | 917,711 | -$259.06K | 0 | 1 | 0 | 0 | 1 |
| OVID | OVID THERAPEUTICS INC | 916,100 | $218.76K | 0 | 1 | 0 | 0 | 1 |
| NVRO | NEVRO CORP | 909,100 | $5.95M | 0 | 1 | 0 | 0 | 1 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 874,251 | -$25.55M | 0 | 1 | 0 | 0 | 1 |
| TDOC | TELADOC HEALTH INC | 871,700 | $526.50K | 0 | 1 | 0 | 0 | 1 |
| WRBY | WARBY PARKER INC-CLASS A | 864,723 | -$53.92M | 0 | 2 | 2 | 0 | 4 |
| BSX | BOSTON SCIENTIFIC CORP | 861,396 | $113.75M | 1 | 3 | 1 | 0 | 6 |
| BDX | BECTON DICKINSON AND CO | 831,627 | $200.85M | 0 | 2 | 3 | 3 | 7 |
| AGL | AGILON HEALTH INC | 827,793 | $4.78M | 0 | 2 | 0 | 0 | 2 |
| TERN | TERNS PHARMACEUTICALS INC | 810,700 | $505.22K | 0 | 1 | 0 | 0 | 1 |
| CERS | CERUS CORP | 794,181 | -$2.08M | 0 | 1 | 1 | 0 | 2 |
| NKTR | NEKTAR THERAPEUTICS | 790,995 | -$439.82K | 0 | 1 | 0 | 0 | 1 |
| CRON | CRONOS GROUP INC | 727,312 | $1.23M | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q1 2025
What are the most bought Healthcare stocks in Q1 2025?
The most bought healthcare stocks in Q1 2025 are those with the largest increase in reported share counts across tracked institutional investors compared to Q4 2024, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2025?
Among the managers we track, net additions were largest in companies such as GSK PLC-SPON ADR (GSK), BAXTER INTERNATIONAL INC (BAX), OPTION CARE HEALTH INC (OPCH), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q4 2024).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.